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FRET-based biosensor experiments in adult cardiomyocytes are a powerful way of dissecting the spatiotemporal dynamics 
of the complicated signaling networks that regulate cardiac health and disease. However, although much information has 
been gleaned from FRET studies on cardiomyocytes from larger species, experiments on adult cardiomyocytes from mice 
have been difficult at best. Thus the large variety of genetic mouse models cannot be easily used for this type of study. 
Here we develop cell culture conditions for adult mouse cardiomyocytes that permit robust expression of adenoviral FRET 
biosensors and reproducible FRET experimentation. We find that addition of 6.25 µM blebbistatin or 20 µM (S)-nitro-
blebbistatin to a minimal essential medium containing 10 mM HEP ES and 0.2% BSA maintains morphology of cardiomyocytes 
from physiological, pathological, and transgenic mouse models for up to 50 h after adenoviral infection. This provides a 
10–15-h time window to perform reproducible FRET readings using a variety of CFP/YFP sensors between 30 and 50 h 
postinfection. The culture is applicable to cardiomyocytes isolated from transgenic mouse models as well as models 
with cardiac diseases. Therefore, this study helps scientists to disentangle complicated signaling networks important in 
health and disease of cardiomyocytes.
Illuminating cell signaling with genetically encoded 
FRET biosensors in adult mouse cardiomyocytes
Gopireddy Raghavender Reddy1*, Toni M. West1*, Zhong Jian1, Mark Jaradeh1, Qian Shi1, Ying Wang1, Ye Chen‑Izu1,2,3, and Yang K. Xiang1,4
Introduction
FRET-based biosensors are powerful tools for studying intra-
cellular signaling on a single cell, showing time-dependent nu-
ances in cellular changes. But the live-cell imaging–based FRET 
assays have some limitations in adult cardiomyocytes. Namely, it 
normally takes ∼35 h of adenoviral infection to produce enough 
expression of the biosensor protein to allow effective perfor-
mance of the FRET assay. This has been a critical limitation in 
studying adult cardiomyocytes. Up until now, culture of isolated 
adult cardiomyocytes from larger animals such as pigs, rabbits, 
and rats has been effective for FRET assays (Nikolaev et al., 2010; 
Barbagallo et al., 2016; Fields et al., 2016; Wang et al., 2017). But it 
has been difficult to culture isolated adult cardiomyocytes from 
mice because they either enter apoptosis or dedifferentiate over a 
35–50-h period needed for FRET sensor expression. In other spe-
cies’ cardiomyocytes, it has been found that calcium tolerance and 
cell attachment to the substrate are two important factors for gen-
erating long-term cultures (Louch et al., 2011), and it is thought 
that calcium intolerance plays an important role in mouse cardio-
myocyte toxicity in long-term cultures (Bers, 2002). Hence, the 
limitations of mouse cardiomyocyte extended culture morphol-
ogy has made adult mouse cardiomyocyte FRET difficult at best.
To overcome this major challenge, the Nikolaev laboratory has 
developed transgenically expressed FRET sensors in mice (Götz 
et al., 2014; Sprenger et al., 2015). This is an important contri-
bution to overcoming a large hurdle, but these sensors have low 
signal-to-noise ratio because of poor expression. Additionally, a 
new mouse genetic line must be developed for each sensor, which 
is expensive and time intensive. Furthermore, exploring the 
ramification of any genetic knockout mouse model with FRET 
methods means additionally crossbreeding the mice together, 
which lengthens the time for the experiment greatly and may 
be financially prohibitory. Because of these limitations, many 
avenues of research remain untouched because the myriad of 
available transgenic mouse models are inaccessible.
Previous attempts have also been made to culture adult 
mouse cardiomyocytes for FRET. We have previously reported a 
method for performing FRET with the PKA biosensor AKAR2.2 
on WT adult mouse cardiomyocytes where cells were cultured 
in MEM containing 2.5% FBS for 24 h after infection (Soto et al., 
2009). The Nikolaev group has reported a similar method for 
performing FRET measurements of cAMP ∼24 h after biosensor 
transfection on WT adult mouse cardiomyocytes where the cells 
are cultured in MEM containing 0.1 mg/ml BSA (Börner et al., 
2011) but has since moved to using the transgenically modified 
FRET sensor–expressing mice. The Zaccolo group also reported 
a technique for performing FRET on adult mouse cardiomyocytes 
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where cytochalasin D is implemented to improve cell morphol-
ogy at 24 h after infection (Lomas et al., 2015). For these studies, 
because the FRET assay is done 24 h after infection, the signal-to-
noise ratio is poor; and still, there are difficulties getting a large 
number of data points because of low numbers of surviving cells 
(Lomas et al., 2015). We hypothesized that using a tried-and-true 
method for FRET biosensor expression—that of adenovirus in-
fection—combined with an optimized culturing condition would 
be able to solve these problems effectively. In the present study, 
we have found a method for culturing and infecting isolated adult 
cardiomyocytes from mice to effectively do FRET analysis.
In initial trials, A kinase activity reporter 3 (AKAR3; Allen and 
Zhang, 2006) was implemented as the biosensor to show proof 
of principle and to optimize the culture conditions. AKAR3 is a 
cyan fluorescent protein/yellow fluorescent protein (CFP/YFP) 
sensor that detects PKA activity (Allen and Zhang, 2006; Ni et al., 
2006). Once conditions for FRET using AKAR3 were established in 
adult mouse cardiomyocytes, other CFP/YFP sensors of Epac-SH187 
(Klarenbeek et al., 2015), cGMP indicator-500 nM (cGi500; 
Russwurm et al., 2007), and Camui (Takao et al., 2005) were 
also effectively used. These sensors detect cAMP concentration, 
cGMP concentration, and calcium/calmodulin-dependent kinase 
II (CaMKII) activity, respectively. In our culture, overall morphol-
ogy, sarcomere length, and a majority of protein expression pro-
files tested did not significantly change over the culturing period, 
signifying that signaling networks are well maintained under this 
protocol. Moreover, AKAR3 was expressed in cardiomyocytes 
from transgenic β-1 adrenergic receptor knockout mice (β1KO), 
and differential responses to isoproterenol could be observed. Fi-
nally, AKAR3 was expressed in cardiomyocytes from healthy and 
diabetic animals, and differential responses to isoproterenol could 
be observed in diabetic cardiomyocytes compared with normal 
cells. Fig. 1 A depicts a flow chart of the method to perform FRET 
on adult mouse cardiomyocytes. The future utilization of FRET 
biosensors in a variety of transgenic mouse cardiomyocytes will 
permit researchers to broadly explore cardiomyocyte signaling 
cascades important in health and disease in hearts.
Materials and methods
Animal welfare
All animal care and experimentation followed National Institutes 
of Health (NIH) guidelines and were approved by the University 
of California Davis Institutional Animal Care and Use Committee. 
Animals were euthanized under general anesthesia (induction 
with 2–5% isoflurane in 100% oxygen until reflex to toe pinch 
was not present).
Reagents and materials
All reagents and materials were obtained from Millipore-Sigma 
unless otherwise specified.
Cardiomyocyte isolation methods
Three different techniques for isolating adult mouse cardiomy-
ocytes were assessed for FRET culture, where cardiomyocytes 
were separated from other cell types. In all cases, only cardio-
myocytes could be observed in the cultures; no other cell types 
were detected. For a majority of the mouse experimentation, 
cardiomyocytes from 8–10-wk-old male WT C57BL/6J mice (Jack-
son Laboratory) were isolated. When comparing FRET response 
between WT and β1KO (Devic et al., 2001), all cells were isolated 
from 8–10-wk-old mice on a Friend leukemia virus B background. 
For trials using diabetic cardiomyocytes, cells were isolated from 
C57BL/6J mice that were fed either a high-fat diet (HFD; 60% fat; 
Research Diets; D12492J) for 5–6 mo until they developed diabetic 
cardiomyopathy or normal chow diet (10% fat; Research Diets; 
D12450J) as control for the same length of time (Wang et al., 2017).
The primary isolation method implemented for mouse car-
diomyocytes has been previously described (Zhou et al., 2000). 
Mice were injected with 5,000 units/kg heparin (Fresenius Kabi) 
and anesthetized in 2–5% isoflurane, and hearts were excised 
and placed in a bath of ice-cold perfusion buffer (120 mM NaCl, 
5.4 mM KCl, 1.2 mM NaH2PO4, 20 mM NaHCO3, 1.2 mM MgSO4, 
5.6 mM glucose, 10 mM 2,3-butanedione monoxime [BDM], and 
20 mM taurine, pH 7.34, bubbled with carbagen [Airgas] for 10 
min, 0.22-µm filtered). The aorta was cannulated onto a 22-
gauge gavage needle with a 1.2-mm ball (VWR) and transferred 
onto the perfusion apparatus (Radnoti) with buffer perfused at 
a constant flow rate of 7 drops/10 s by a Masterflex C/L (Cole 
Parmer). An Isotemp Circulator/Bath (Thermo Fisher Scientific) 
maintained the perfusate at a temperature of 37°C. The heart was 
predigested with 15 ml perfusion buffer containing 2.5 mg colla-
genase II (Worthington), 0.5 mg protease XIV, and 0.1% BSA. The 
heart was then digested with 20 ml perfusion buffer containing 
10 mg collagenase II, 2 mg protease XIV, 0.1% BSA, and 50 µM 
CaCl2, which was recirculated through the system until the heart 
was digested, as determined by touch. The heart was cut below 
the atria into a dish containing 5 ml digestion buffer and disso-
ciated using forceps. The supernatant was placed in 5 ml stop 
buffer (12.5 µM CaCl2 and 10% FBS in perfusion buffer) and was 
centrifuged at 500 rpm for 1 min. Remaining particles of tissue 
were further digested with 5 ml digestion buffer for 5 min at 37°C 
twice more to ensure maximal yield of cells. Succeeding steps 
were followed in each digestion sample in tandem. Cell pellets 
were resuspended and recovered in a gradient of calcium buffers 
to a concentration of 1 mM.
The second method for isolating cells was reported previously 
for use in preparation of cardiomyocytes for FRET analysis and 
uses gravity-fed pressure for perfusion (Lomas et al., 2015). Mice 
were injected with 5,000 units/kg heparin and anesthetized in 
2–5% isoflurane. The aorta was clipped and cannulated onto a 22-
gauge gavage needle with a 1.2-mm ball attached to a 1-ml syringe 
containing Tyrode buffer (130.0 mM NaCl, 5.6 mM KCl, 3.5 mM 
MgCl2, 5.0 mM HEP ES, 10.0 mM glucose, 20.0 mM taurine, and 
0.4 mM Na2HPO4, pH 7.4, 0.22-µm filtered), and the needle was 
transferred onto the perfusion apparatus with buffer perfusion 
administered by gravity-fed pressure. An Isotemp Circulator/
Bath attached to the perfusion apparatus maintained the perfu-
sate at a temperature of 37°C. Once Tyrode solution was perfu- 
sing through the heart at a constant rate, the buffer was switched 
to Tyrode buffer containing 0.5 mg/ml collagenase II, 0.1 mg/ml 
protease XIV, 0.1% BSA, and 100 µM CaCl2. Digestion was stopped 
when the drip rate dramatically increased. The heart was cut 
below the atria into a dish containing 5 ml digestion buffer and 
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Figure 1. Morphology of adult cardiomyocytes from mouse, 
rat, and rabbit in different culturing conditions. (A) Flow 
chart of workflow for performing FRET assay on adult mouse 
cardiomyocytes. (B) Bright-field images of adult rabbit cardio-
myocytes at 0- and 40-h time points that were maintained in 
DMEM. (C) Bright-field images of adult rat cardiomyocytes at 0- 
and 40-h time points that were maintained in M1018 containing 
10 mM BDM. (D) Bright-field images of adult mouse cardiomy-
ocytes at 0- and 40-h time points maintained in M1018 alone, 
M1018 with 10 mM BDM, or M1018 with 25 µM blebbistatin. 
All the bright-field images were captured at 20× magnification. 
Scale bar = 100 µm. (E) Sarcomere length measurements of car-
diomyocytes at the normal time of infection (0 h) and 40 h later. 
(F and G) Western blot scans (F) and analysis (G) at the normal 
time of infection (0 h) and 40 h later of proteins important in 
proper functionality of cardiomyocytes. PKA RIIα, protein kinase 
A regulatory subunit IIα; SER CA2A, sarcoplasmic-endoplasmic 
reticulum calcium ATPase 2A. *, P ≤ 0.05 by unpaired t test. Error 
bars represent ±SEM.
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dissociated using forceps and 30  s of trituration with a 3-ml 
transfer pipette. 5 ml stop buffer (Tyrode buffer containing 1% 
BSA) was added, and the solution was filtered through 250-µm 
mesh. The suspension was centrifuged at 500 rpm for 1 min. Cells 
were resuspended and recovered in a gradient of calcium buffers 
to a concentration of 1 mM.
A third method for mouse cardiomyocyte isolation that has 
been previously described (Jian et al., 2016) was implemented 
to determine whether a pressure monitor in combination with 
using KCl as the sole inhibitor of heart beating would produce 
better cell quality for FRET than the above two methods. Mice 
were injected with 5,000 units/kg heparin and anesthetized 
in 2–5% isoflurane. Perfusion buffer (113  mM NaCl, 4.7  mM 
KCl, 1.2 mM MgSO4, 0.6 mM Na2HPO4, 0.6 mM KH2PO4, 12 mM 
NaHCO3, 10 mM KHCO3, 10 mM HEP ES, and 5 mM glucose, pH 7.4, 
0.22-µm filtered) was injected into the femoral artery to arrest 
heart contraction. The aorta was clipped and cannulated onto a 
22-gauge gavage needle with a 1.2-mm ball. The heart was excised 
from the chest, and the needle was transferred onto the perfusion 
apparatus with buffer perfusion administered by the Masterflex 
C/L. The flow rate was adjusted to maintain a pressure of 50–70 
mmHg, which was measured using a BLPR2 pressure transducer 
(WPI) and SYS-BP1 pressure monitor (WPI). Perfusate tempera-
ture was maintained at 37°C by an Isotemp Circulator/Bath. 
After the perfusate was clear of blood, the system was switched 
to 50 ml digestion solution (300 units/ml collagenase II, 0.04 
mg/ml protease XIV, and 12.5 µM CaCl2 in perfusion buffer). The 
pump rate was adjusted continually to maintain a constant pres-
sure between 50 and 70 mmHg until there was a dramatic drop 
in pressure to ∼30 mmHg. The heart was then cut below the atria 
into a dish containing 30 ml stop buffer (10% FBS and 12.5 µM 
CaCl2 in perfusion buffer) and was dissociated using forceps and 
30 s of trituration with a 3-ml transfer pipette. The suspension 
was filtered through a 250-µm mesh and centrifuged at 500 rpm 
for 1 min. Cells were resuspended and recovered in a gradient of 
calcium buffers to a concentration of 1 mM.
The isolation procedure for Zucker rat adult cardiomyocytes 
has been previously reported (Zhou et al., 2000). In essence, the 
same procedure was performed for rat isolation as was indicated 
in the primary protocol for mouse isolation, with the following 
modifications. The heart was cannulated onto a blunted 17-gauge 
needle (VWR); predigested with 30 ml perfusion buffer contain-
ing 5.0 mg of collagenase II, 1.0 mg protease XIV, and 0.1% BSA; 
and digested with 40 ml perfusion buffer containing 20 mg col-
lagenase II, 4 mg protease XIV, 0.1% BSA, and 50 µM CaCl2. The 
heart was cut into a dish containing 10 ml digestion buffer, and 
the supernatant was placed in 10 ml stop buffer (12.5 µM CaCl2 
and 10% FBS in perfusion buffer).
New Zealand white rabbit cardiomyocytes were isolated as 
previously described (Madhvani et al., 2011). Rabbits were anes-
thetized with 5% isoflurane and injected with 5,000 units/kg 
heparin before the heart was excised. Hearts were placed in an 
ice-cold bath of perfusion solution (138 mM NaCl, 5.4 mM KCl, 
1 mM MgCl2, 0.33 mM NaH2PO4, 10 mM NaHCO3, 2 mM glucose, 
10 mM HEP ES, 2.5 mM pyruvic acid, and 10 units/L insulin, pH 
7.4, 0.22 µm filtered) containing 1 mg/ml BSA and cannulated 
onto a Tygon tubing connector (Radnoti). The Tygon tubing con-
nector was transferred onto the perfusion apparatus with buffer 
perfusion administered by the Masterflex C/L until the perfusate 
was clear of blood while an Isotemp Circulator/Bath maintained 
the perfusate temperature at 37°C. The heart was then digested 
with 150 ml perfusion buffer containing 150 mg collagenase II 
and 8 mg protease XIV which was recirculated through the sys-
tem until the heart was digested, as determined by touch. The 
heart was cut below the atria into a dish containing perfusion 
buffer with BSA, cut into pieces, and triturated for 30 s with a 
3-ml transfer pipette. The resulting suspension was filtered 
through a 250-µm mesh and centrifuged at 500 rpm for 1 min. 
The cell pellet was resuspended and recovered in a gradient of 
calcium buffers to a concentration of 1 mM.
Cardiomyocyte culture conditions
M1018 was made according to the manufacturer’s directions, using 
cell culture–grade NaHCO3 and penicillin-streptomycin-glutamate 
(Mediatech). Medium was further supplemented, as indicated, 
with 10 mM BDM, 0.5 µM cytochalasin D, 10 mM HEP ES, 0.2% 
BSA, 10% FBS, 5 mM taurine, and/or 1× insulin-transferrin-sele-
nium (ITS; Thermo Fisher Scientific). pH was adjusted to 7.35 or 
7.8 using NaOH (Thermo Fisher Scientific) and HCl (Thermo Fisher 
Scientific). All media were 0.22-µm sterile filtered before use. 
(-)-Blebbistatin (Cayman) or (S)-nitro-blebbistatin (Cayman) was 
dissolved to a concentration of 25 mM in filtered, cell culture–grade 
DMSO before being further diluted, as indicated, into the medium.
Cell culturing and infection
#0 glass coverslips (Karl Hecht) were coated in laminin (Life 
Technologies). Laminin was diluted 100× in sterile-filtered ddPBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4, 
pH 7.4). 100 µl of the diluted laminin was placed on each coverslip, 
which was placed in a 37°C incubator with 5% carbon dioxide for 
a minimum of 2 h. Coverslips were moved to 24-well plate wells 
(Falcon) and washed three times with sterile-filtered ddPBS.
For most cultures, 20,000 cells were plated per each lami-
nin-coated #0 glass coverslip in a 24-well plate in 500 µl of 10% 
serum-containing medium for 5 h in a 37°C incubator with 5% car-
bon dioxide. Medium was then replaced with 500 µl serum-free 
medium containing virus coding for the specified FRET biosen-
sor and then placed at 37°C with 5% carbon dioxide. For cultures 
using the previously reported cytochalasin D–containing medium 
(Lomas et al., 2015), 20,000 cells were plated in 500 µl of 2.5% se-
rum-containing medium for 2 h, switched to serum-free medium 
containing the virus for 3 h, and then switched to serum-free 
medium containing 0.5 µM cytochalasin D for 25 h. The AKAR3, 
Epac-SH187 (Epac-based sensor #H187), ICUE3 (indicator of cAMP 
using Epac 3), Camui, and cGi500 sensors have all been previously 
described (Takao et al., 2005; Allen and Zhang, 2006; Russwurm 
et al., 2007; DiPilato and Zhang, 2009; Klarenbeek et al., 2015). 
Viruses were produced using the AdEasy system (Luo et al., 2007; 
Qbiogene). 95–99% of cells were infected within each experiment.
Microscope image acquisition
At the specified time points after infection, the medium was 
changed to serum-free medium without virus. The glass cov-
erslip was transferred to a glass-bottom culture dish (MatTek) 
Reddy et al. 
Optimization of FRET in mouse adult cardiomyocytes
Journal of General Physiology
https://doi.org/10.1085/jgp.201812119
1571
containing 3 ml room temperature ddPBS. For cells cultured in 
blebbistatin-containing medium, the ddPBS was also supple-
mented fresh daily with 1 µM blebbistatin.
A Zeiss AXIO Observer A1 inverted fluorescence microscope 
equipped with a Hamamatsu Orca-Flash 4.0 digital camera and 
controlled by Metaflor software (Molecular Devices) acquired 
phase-contrast, CFP480, and FRET images. Phase-contrast and 
CFP480 images were collected with 20× and 40× oil-immersion 
objective lenses, and FRET images were collected using a 40× 
oil-immersion objective lens. Images for FRET analysis were 
recorded by exciting the donor fluorophore at 430–455 nm and 
measuring emission fluorescence with two filters (475DF40 for 
cyan and 535DF25 for yellow). Background subtraction of each 
fluorophore channel was performed by measuring the intensity 
of signal in an area of the imaging dish that had no cells present 
and subtracting it from the values present in cells of that dish. 
Images were acquired every 30 s, with exposure time of 200 ms 
on each channel. The donor/acceptor FRET ratio was calculated 
and normalized to the ratio value of baseline. CFP images were 
acquired by exciting the donor fluorophore at 430–455 nm and 
measuring emission fluorescence with the 475DF40 filter for 25 
ms. Phase-contrast images were collected using a broad-spec-
trum incandescent light without filters for 25 ms.
Once cells normalized to UV exposure under FRET analysis 
conditions, an appropriate stimulant was added to the glass-bot-
tom culture dish, and the change in FRET ratio was recorded. 
10−5  M forskolin (IC Lab) + 10−4  M 3-isobutyl-1-methylxan-
thine (IBMX; Calbiochem) or 10−7 M isoproterenol were applied 
with AKAR3, ICUE3, and Epac-SH187; 5 × 10−5  M sodium nitro-
prusside (SNP) was applied for cGi500; and 2 × 10−4  M CaCl2 
was applied for Camui. Average normalized curves and aver-
age maximal responses to stimulation were graphed based on 
FRET ratio changes.
Sarcomere length
Sarcomere length was measured as previously described (Jian 
et al., 2014). Freshly isolated adult mouse cardiomyocytes were 
placed on laminin-coated coverslips and incubated at 37°C and 
5% carbon dioxide for 5 h in M1018 supplemented with 6.25 µM 
blebbistatin, 10 mM HEP ES, 0.2% BSA, and 10% FBS. Medium was 
changed to serum-free medium of the same blend. Sarcomere 
length was then measured (0 h) and again measured 40 h later 
using an IonOptix system to implement a fast Fourier transform 
algorithm to estimate the light–dark striation pattern frequency 
in the cardiomyocyte. This striation pattern frequency, recorded 
in sarcomeres per pixel using a high-speed camera (MyoCam-S at 
240–1,000 frames/s), was converted to sarcomere length by using 
a calibration slide with 2.5-µm increments (Edmund Industrial 
Optics UV Fused Silica Ronchi Slide, 400 lines/mm) to provide 
the software with a pixels-per-distance conversion factor. This 
conversion factor allowed for conversion from sarcomeres per 
pixel to distance per sarcomere.
Western blot
Adult mouse cardiomyocytes from a given mouse were plated 
in two laminin-coated 5-cm dishes at a concentration of 40,000 
cells/ml in M1018 containing 6.25  µM blebbistatin, 10  mM 
HEP ES, 0.2% BSA, and 10% FBS. Cells were incubated at 37°C 
for 5 h. The medium was then changed to serum-free medium 
of the same blend. One well was lysed with radioimmunopre-
cipitation assay buffer (25 mM Tris HCl, pH 7.6, 150 mM NaCl, 
1% IGE PAL, 1% sodium deoxycholate, 0.1% SDS, and 1 mM EDTA 
containing protease and phosphatase inhibitors [100 mM Na3F, 
1 mM Na2VO4, 1 mM glycerol, 2.5 mM NaP2O7, 10 µg/ml leupeptin, 
1 mM PMSF, and 10 µg/ml aprotinin]) at this time point, which 
is when viral infection for FRET experimentation normally takes 
place. The second well of cells from each mouse was lysed with 
radioimmunoprecipitation assay buffer (25 mM Tris HCl, pH 7.6, 
150 mM NaCl, 1% IGE PAL, 1% sodium deoxycholate, 0.1% SDS, and 
1 mM EDTA containing protease and phosphatase inhibitors [100  
mM Na3F, 1 mM Na2VO4, 1 mM glycerol, 2.5 mM NaP2O7, 10 µg/ml 
leupeptin, 1 mM PMSF, and 10 µg/ml aprotinin]) 40 h later, which 
is the time that FRET experimentation normally takes place. Total 
protein concentrations were normalized after bicinchoninic acid 
assay (Pierce) detection. Replicates from three mice were resolved 
simultaneously by SDS-PAGE on a 4–20% gradient gel and trans-
ferred to polyvinylidene fluoride membrane. Primary antibodies 
that were implemented for protein detection were troponin I (TnI; 
4002; Cell Signaling), cardiac-specific myosin binding protein c 
(c-MyBPC; gift from S. Sadayappan, University of Cinicinnati, 
Cincinnati, OH; Sadayappan et al., 2006), sarcoplasmic-endo-
plasmic reticulum calcium ATPase 2A (SER CA2A; 2A7-A1; Thermo 
Fisher Scientific), RyR (34C; Thermo Fisher Scientific), protein 
kinase A regulatory subunit IIα (612243; BD), CaMKII (sc-5306; 
Santa Cruz), caspase 3 (Casp3; sc-2171759; Santa Cruz), caspase 9 
(Casp9; sc-56076), and GAP DH (97166; Cell Signaling). Visualiza-
tion was actualized with an Odyssey scanner (Li-Cor) after incu-
bation in either antirabbit or antimouse IRDye 680CW or 800CW. 
Band intensities were quantified with ImageJ (NIH), divided by 
GAP DH values, and normalized to the average of the 0-h values.
Statistical analysis
All values are presented as mean ± SEM, and either unpaired 
t tests or one-way ANO VA with Bonferroni post hoc test was 
performed between mean values where indicated using 
GraphPad Prism 7.
Results
Blebbistatin preserves adult mouse 
cardiomyocyte morphology
Adult rabbit cardiomyocytes were cultured in DMEM, and adult 
rat cardiomyocytes were cultured in M1018 containing 10 mM 
BDM. As previously reported (Barbagallo et al., 2016), rabbit and 
rat cardiomyocytes retained rectangular morphology after 40 h 
of adenovirus infection (Fig. 1, B and C). Mouse cardiomyocytes 
were placed in similar culturing conditions, congruent with the 
methods reported by us and the Nikolaev group (Fig. 1 D; Soto 
et al., 2009; Börner et al., 2011; Wright et al., 2014). After 40 h, 
very few adult mouse cardiomyocytes in these cultures retained 
rectangular morphology. However, when the previously reported 
in vitro skeletal muscle myosin II KI concentration of 25 µM bleb-
bistatin (Kovács et al., 2004) was included in the medium, the 
adult mouse cardiomyocytes retained normal morphology as 
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previously reported (Kabaeva et al., 2008). To further explore 
whether the cells cultured in the blebbistatin media had any dis-
cernable changes in the extended culture time, we measured sar-
comere length and examined protein concentrations by Western 
blot. There was not a significant difference in sarcomere length 
between freshly isolated cells and cells cultured for 40  h, the 
normal time that the FRET assay is performed (Fig. 1 E). The sar-
comere lengths were within previously measured length ranges 
for healthy mouse cardiomyocytes at rest (King et al., 2011). In 
addition, there were no significant changes to myofilament pro-
teins (TnI and c-MyBPC), excitation contraction coupling pro-
teins (SER CA2A and RyR), kinases (PKA-RIIα and CaMKII), and 
caspase 3, but there was a significant increase in caspase 9 at the 
40-h time point (Fig. 1, F and G).
CFP images of cardiomyocytes 40 h after infection with the 
PKA biosensor AKAR3 were then captured to determine whether 
FRET would be possible. However, 25 µM blebbistatin and 0.05% 
DMSO yielded a large deposition of fluorescent spots that would 
make FRET practically impossible (Fig. 2 A). Increasing DMSO 
concentration to 0.1% had no effect on fluorescent deposition of 
blebbistatin (not depicted). Therefore, reduced concentrations of 
blebbistatin were attempted together with reduced DMSO con-
centrations. Reducing the blebbistatin concentration to 6.25 µM 
in 0.025% DMSO caused no difference in culture morphology 
while greatly reducing the fluorescent blebbistatin deposition 
(Fig. 2 A). When blebbistatin concentrations were further re-
duced, the morphology of the cultured cells suffered (Fig. 2 A) 
and the cells often shrank when exposed to UV light.
Although using 6.25 µM blebbistatin greatly reduced auto-
fluorescent spotting to allow for reproducible FRET readings, 
we attempted to optimize the media conditions to further re-
duce autofluorescence and improve cell health. Other compo-
nents present in previously published mouse cardiomyocyte 
media (Kabaeva et al., 2008; Ackers-Johnson et al., 2016) were 
supplemented in tandem with 6.25  µM blebbistatin to deter-
mine whether autofluorescence could be further reduced and 
whether cell culture quality could be further improved. Supple-
menting 10 mM HEP ES further reduced autofluorescent spotting 
(Fig. 2 B). Supplementing 0.2% BSA improved cell attachment to 
the coverslip and reduced the number of cells that failed to main-
tain rod shape morphology when placed under UV light, but led 
to increases in autofluorescent spots (Fig. 2 B). When both HEP ES 
and BSA were applied together, the number of autofluorescent 
spots was inconsequential (Fig. 2 B). Meanwhile, supplement-
ing ITS or taurine to the media had no appreciable effect on the 
culture quality or autofluorescent spotting (not depicted). Using 
a medium with pH 7.8 rather than 7.35 had no appreciable im-
provement on the culture (not depicted). (S)-nitro-blebbistatin 
(Képiró et al., 2014; Várkuti et al., 2016) is a derivative of (-)-bleb-
bistatin that is not fluorescent, does not break down in UV light, 
and does not produce reactive oxygen species and phototoxic 
byproducts like blebbistatin when exposed to UV light (Kolega, 
2004; Sakamoto et al., 2005; Mikulich et al., 2012). 20 µM (S)-ni-
tro-blebbistatin was supplemented to the media to determine 
whether the culture quality could be further improved. Cells 
were infected with AKAR3, and at the time of infection as well 
as at 40 h after infection, images were captured. There was no 
significant difference in cell morphology in cells cultured in 
(S)-nitro-blebbistatin compared with cells from the same mice 
cultured in the presence of blebbistatin (Fig. 2, C and D).
Quality adult myocyte culture for optimal expression of PKA 
biosensors and FRET analysis
To determine how long mouse cardiomyocytes would retain 
rod-shape morphology in the newly characterized cell culture 
medium, an image was collected every 10 h after infection with 
the PKA biosensor AKAR3. Cardiomyocytes cultured in the same 
medium without blebbistatin were used as controls. Mouse adult 
myocytes in the culture medium with blebbistatin maintained a 
rectangular morphology for 50 h after infection. At 60 h after in-
fection, cells became rounded on the edges (Fig. 3 A) and tended 
to shrink when exposed to UV light.
Adult mouse cardiomyocytes were cultured in medium con-
taining cytochalasin D as previously reported, in comparison 
(Lomas et al., 2015). At the recommended 25-h time point, 10% 
of cells in the culture had retained rectangular morphology, but 
by 30 h, only very few cells retained this morphology (Fig. 3 B). 
FRET response was also tested 25 h after infection of AKAR3 in 
mouse adult myocytes cultured in the medium with cytocha-
lasin D as previously reported (Lomas et al., 2015), which was 
compared with the FRET response of myocytes cultured with 
blebbistatin. Myocytes in both cultures displayed increases in 
FRET ratio after costimulation with forskolin and IBMX; how-
ever, the cells cultured in cytochalasin D had a significantly lower 
AKAR3 response than the cells cultured in blebbistatin (Fig. 3, 
C–E). Furthermore, the cells cultured in cytochalasin D tended 
to shrink when exposed to UV light, making it difficult to collect 
enough data points. In contrast, very few of the cells cultured in 
blebbistatin shrink when exposed to UV light at this time point. 
Overall, the cytochalasin D–containing medium worked poorly 
to maintain culture quality that is required for extensive analy-
sis of signaling networks, while the newly developed blebbista-
tin-containing medium helped to maintain cell morphology well 
throughout the culture.
Because the blebbistatin-containing culture maintained sig-
naling transduction ability at 25 h postinfection, later time points 
were then further explored to determine the optimal time for 
performing the FRET assay. Phase-contrast and CFP images of 
AKAR3 were collected at 0, 20, 30, 35, 40, 50, and 60 h after in-
fection to optimize the expression of the biosensor for FRET anal-
ysis in mouse adult cardiomyocytes. Rabbit adult cardiomyocytes 
were used as control. A similar expression profile emerged from 
both mouse and rabbit cells (Fig. 4, A and B). To determine the 
time window in which reproducible FRET data can be collected, 
the FRET assay was performed 20, 30, 35, 40, 50, and 60 h after 
infection with AKAR3 by stimulating the cells with a mixture of 
forskolin and IBMX, which activate adenylyl cyclases and inhibit 
phosphodiesterases, respectively (Fig. 5, A–D). Compared with 
rabbit cardiomyocytes, adult mouse cardiomyocytes produced 
a peak reproducible response earlier, at 35 h postinfection. Re-
sponses were similar from 35 to 50 h in mouse cells. By the 60 h 
time point, mouse cardiomyocytes were unresponsive to stimuli, 
while rabbit cardiomyocytes were even more responsive (Fig. 5, 
A–D). We also determined how cells cultured in the nonfluores-
Reddy et al. 
Optimization of FRET in mouse adult cardiomyocytes
Journal of General Physiology
https://doi.org/10.1085/jgp.201812119
1573
cent derivative, (S)-nitro-blebbistatin, would perform in FRET 
assays. FRET was performed on cells from the same animals 
cultured in media containing 20 µM (S)-nitro-blebbistatin 40 h 
after infection with AKAR3. There was no significant difference 
in FRET response in cells cultured in (S)-nitro-blebbistatin com-
pared with those with blebbistatin (Fig. 5, E and F).
Translation of the FRET assays to varying myocyte isolation 
protocols, mouse models, and FRET-based biosensors
Assays that are commonly done using isolated adult cardiomyo-
cytes, including patch-clamp experiments, require healthy cells 
with intact membrane structure that are free of substances such 
as BDM or taurine. There is also often debate about which isola-
tion method needs to be performed for a given assay (Louch et 
al., 2011; Jian et al., 2016). We checked three isolation methods 
to see whether our newly developed FRET assay was dependent 
on a specific isolation protocol, as was suggested in a previous 
study on mouse cardiomyocyte FRET (Lomas et al., 2015). Differ-
ences in the isolation methods included changes in the contents 
of the isolation buffer, changes in how the heart was excised and 
cannulated, and changes in how perfusion was regulated. The 
methods for isolation are detailed in the Materials and methods 
section. All three isolation methods had similar robust results for 
cell culture and AKAR3 FRET biosensor analysis (Table 1).
The proposed culturing method was also tested in adult mouse 
cardiomyocytes isolated from β1KO mice to show the proof of 
principle that the method is applicable to transgenic mouse cells. 
The data shown in Fig. 6 (A and B) demonstrate that adult β1KO 
cardiomyocytes have a similar response to cotreatment with 
forskolin and IBMX as WT cells but have a reduced response to 
Figure 2. Media optimization to eliminate autofluorescent properties in adult cardiomyocyte culture. (A) CFP images of adult mouse cardiomyocytes 
40 h after infection with the PKA FRET biosensor, AKAR3, maintained in M1018 with different doses of blebbistatin. Images were recorded at 40× magnification. 
Scale bar = 100 µm. (B) CFP images of adult mouse cardiomyocytes 40 h after infection with AKAR3 maintained in M1018 with 6.25 µM blebbistatin, 0.2% 
BSA, and 10 mM HEP ES as indicated. Images were recorded at 40× magnification. Scale bar = 100 µm. (C) Bright-field images, recorded at 20× magnifica-
tion at the time of infection (0 h) and 40 h later, of myocytes cultured in M1018 with 10 mM HEP ES and 0.2% BSA, and either 6.25 µM blebbistatin or 20 µM 
(S)-nitro-blebbistatin. Scale bar = 100 µm. (D) Bright-field and CFP images collected at the time of infection (0 h) and 40 h later. Images were recorded at 40× 
magnification. Scale bar = 100 µm.
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Figure 3. Blebbistatin improves morphology of adult mouse cardiomyocytes during extended culture. (A) Bright-field images of adult mouse cardio-
myocytes every 10 h when cultured in M1018 + HEP ES + BSA with or without 6.25 µM blebbistatin. (B) Bright-field images displaying the morphology of adult 
mouse cardiomyocytes at previously recommended time points with either 6.25 µM blebbistatin or 500 nM cytochalasin D in the medium. Bright-field images 
were photographed at 20× magnification. Scale bar = 100 µm. (C) CFP images of adult mouse cardiomyocytes 25 h after infection with AKAR3 when cultured 
in medium containing either 6.25 µM blebbistatin or 500 nM cytochalasin D. CFP images were collected at 40× magnification. Scale bar = 100 µm. (D and E) 
Mouse myocytes cultured with blebbistatin and cytochalasin D were costimulated with 10 µM forskolin (FSK) and 100 µM IBMX 25 h after infection with AKAR3 
biosensor. The normalized FRET ratios over time are plotted as an average trace, and maximal increases in AKAR3 FRET ratio are depicted in the bar graph. 
***, P ≤ 0.001 by unpaired t test. Error bars represent ±SEM.
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isoproterenol, an agonist of β adrenergic receptors. Meanwhile, 
cardiomyocytes were also isolated from mice with diabetic car-
diomyopathy after feeding with HFD to show that this method 
for FRET analysis is translatable to cardiac disease models. HFD 
cardiomyocytes displayed a reduced response to isoproterenol 
compared with cells from age-matched littermate controls fed 
with normal chow diet (Fig. 6, C and D). This observation indi-
cates that in pathological diabetic cardiomyocytes, the β-adren-
ergic response is impaired.
The newly developed culturing method was then tested with 
a variety of CFP/YFP-based biosensors. Isolated adult mouse car-
diomyocytes were infected with the sensors cGi500 for cGMP, 
Camui for CaMKII, and ICUE3 and Epac-SH187 for cAMP (Takao et 
al., 2005; Allen and Zhang, 2006; Russwurm et al., 2007; DiPilato 
Figure 4. Time-dependent expression of the PKA FRET biosensor, AKAR3, in adult mouse and rabbit cardiomyocytes. (A and B) Bright-field and corre-
sponding CFP fluorescence images of adult mouse (A) and rabbit (B) cardiomyocytes at different time points of culture as indicated. All images were acquired 
at 40× magnification. Scale bar = 100 µm.
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and Zhang, 2009; Erickson et al., 2011; Klarenbeek et al., 2015). 
Both cGi500- and Camui-infected adult mouse cardiomyocytes 
showed a robust change in FRET ratio upon treatment with ac-
tivators of the sensors from 35 to 50 h postinfection (Fig. 6, E, 
F, and H). ICUE3-infected adult mouse cardiomyocytes, no mat-
ter the length of expression, never produced a robust change in 
FRET ratio when treated with forskolin combined with IBMX. 
The expression of ICUE3 was low, especially in the CFP channel 
Figure 5. Optimization of the expression time of AKAR3 for reproducible FRET measurements in adult cardiomyocytes. (A–D) Adult mouse and rabbit 
cardiomyocytes expressing the PKA biosensor, AKAR3, were costimulated with 10 µM forskolin (FSK) and 100 µM IBMX. The traces depict time courses of 
changes in FRET ratio, and the maximal increases of FRET ratio are plotted in the bar graphs. *, P ≤ 0.05; ***, P ≤ 0.001 by one-way ANO VA followed by post 
hoc Bonferroni test. (E) WT mouse myocytes cultured in medium containing either 6.25 µM blebbistatin or 20 µM (S)-nitro-blebbistatin that were expressing 
the PKA biosensor, AKAR3, were stimulated with 10 µM FSK + 100 µM IBMX, and the average FRET ratios over time were plotted as a trace. (F) The average 
maximal increases in AKAR3 FRET ratio in myocytes from part E were plotted. Significance was calculated by unpaired t test. Error bars represent ±SEM.
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(not depicted). In comparison, the recently developed cAMP 
sensor, Epac-SH187 (Klarenbeek et al., 2015), displayed robust 
changes in FRET ratio in adult mouse cardiomyocytes 30–40 h 
after infection upon stimulation with forskolin and IBMX com-
bined (Fig. 6, G and H). Table 2 details optimal expression and 
experimental windows of individual biosensors in adult mouse 
cardiomyocytes.
Discussion
In this study, a new cell culturing protocol for adult mouse car-
diomyocytes was developed that allows for exploration of intra-
cellular signaling transduction using FRET-based biosensors 
through adenoviral-mediated expression. This method is highly 
adaptable to a variety of isolation techniques, which is a major 
point of concern in many other types of live cardiomyocyte as-
says such as patch-clamp experiments (Louch et al., 2011; Jian 
et al., 2016). Application of this method will allow a variety of 
genetic and pathological mouse models to be used to determine 
on a single-cell, time-dependent basis how signaling cascades in 
cardiomyocytes operate. Data presented in this paper show that 
the culturing method allows for transgenic and diseased mouse 
cardiomyocytes to be assayed with FRET techniques in similar 
fashion to normal WT cells. The culturing method presented here 
simplifies investigation of mouse cardiomyocyte signaling net-
works, as there is no need for complicated breeding schemes to 
cross transgenic biosensor-expressing mice with other genetic 
mouse models. Future implementation of this method in labora-
tories which use a diverse set of isolation techniques will allow 
a variety of genetic mouse models to be used to determine on a 
single-cell, time-dependent basis how signaling cascades in car-
diomyocytes operate.
The main component in the media that improves culture 
conditions is blebbistatin. Previous research done on how to cul-
ture adult mouse cardiomyocytes for long-term studies shows 
that a culture medium containing blebbistatin improves short-
term morphology and long-term survivorship (Kabaeva et al., 
2008). Blebbistatin is a small molecule that selectively inhibits 
myosin II ATPase activity in an uncompetitive manner with the 
actin-detached state, which leads to relaxation of myofibrils 
in contractile cells (Kovács et al., 2004). Data presented in this 
paper shows that blebbistatin is superior over another reported 
myosin II inhibitor, BDM, in maintaining mouse myocyte mor-
phology during extended culture in vitro to accommodate the 
expression of biosensors for FRET assays. This is probably be-
cause BDM also removes phosphate groups off other cytosolic 
proteins (Ostap, 2002) and causes mitochondrial dysfunction in 
cardiomyocytes by acting directly on the electron transport chain 
(Hall and Hausenloy, 2016). Conversely, blebbistatin has fewer 
off-target affects and minimal disturbance to mitochondrial 
health in cardiomyocytes (Hall and Hausenloy, 2016). Therefore, 
it is recommended that BDM be avoided for mouse cardiomyocyte 
culture and blebbistatin be used instead.
Blebbistatin has an in vitro Ki of 25 µM with myosin II in the 
nucleotide-free form and a similar Ki of 24 µM with the holo-
enzyme (Kovács et al., 2004). Using blebbistatin can therefore 
decrease ATP usage by up to 10 times (Kovács et al., 2004), ex-
tending the life of cells by saving energy reserves. But blebbi-
statin is autofluorescent (Swift et al., 2012), making it a difficult 
substance to work with when performing fluorescence imaging. 
Reducing the blebbistatin concentration to below the holo- and 
apo-enzyme Ki, at a concentration of 6.25 µM, still effectively 
protects cell morphology, sarcomere length, and protein ex-
pression levels in isolated cultures for the extended culture time 
needed for expression of FRET biosensors. Cell morphology and 
biochemistry may be protected at this low blebbistatin concen-
tration because blebbistatin has high affinity with an intermedi-
ate state of nucleotide-bound myosin during its ATPase activity, 
with a measured KM of 3.1 µM (Kovács et al., 2004). Low blebbi-
statin concentration allows for a reduction in the amount of aut-
ofluorescence, which enables FRET to be performed for a 10–15-h 
window without excessive damage to cell morphology.
Blebbistatin is unstable in blue-UV light and has been re-
ported to produce reactive oxygen species and phototoxic by-
products when it breaks down (Kolega, 2004; Sakamoto et al., 
2005; Mikulich et al., 2012). One of the nonfluorescent deriv-
atives, (S)-nitro-blebbistatin (Képiró et al., 2014; Várkuti et 
al., 2016), was supplemented into the culture media instead of 
blebbistatin. When cells cultured in (S))-nitro-blebbistatin were 
tested side by side with cells cultured in blebbistatin, no discern-
able difference in morphology or FRET response was observed. 
Therefore, (S)-nitro-blebbistatin can be used as an alternative if 
experimentation with blebbistatin results in unmanageable flu-
orescence spots and/or myocyte cytotoxicity.
Table 1. Isolation protocol comparison
Procedure Protocol 1 Protocol 2 Protocol 3
Buffer delivery Constant flow by minipump Gravity-induced flow Constant pressure monitored and adjusted 
by minipump
Cannulation Excision, then cannulation In-chest cannulation In-chest cannulation
Buffer contents NaCl, KCl, NaH2PO4, NaHCO3, MgSO4, 
glucose, BDM, taurine
NaCl, KCl, MgCl2, HEP ES, glucose, 
taurine, Na2HPO4
NaCl, KCl, MgSO4, Na2HPO4, KH2PO4, 
NaHCO3, KHCO3, HEP ES, glucose
Isolation initial survivorship rate 49–54% rod shaped 73–83% rod shaped 80–90% rod shaped
Basal CFP/YFP ratio (a.u.) 0.9925–1.0051 0.9957–1.0012 0.9802–0.9972
Normalized 40 h AKAR3 FRET 
Ratio change (a.u.)
1.245–1.2514 1.236–1.2416 1.267–1.2692
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Figure 6. Application of FRET measurements in transgenic adult mouse cardiomyocytes and with a variety of FRET biosensors. (A) WT and β1KO 
mouse myocytes expressing the PKA biosensor, AKAR3, were stimulated with 100 nM isoproterenol (ISO) followed by 10 µM FSK + 100 µM IBMX, and the 
average FRET ratios over time were plotted as a trace. (B) The average maximal increases in AKAR3 FRET ratio in WT and β1KO myocytes were plotted. **, 
P ≤ 0.01 by one-way ANO VA followed by post hoc Bonferroni test. (C) Normal chow (NC) and HFD mouse myocytes expressing the PKA biosensor, AKAR3, 
were stimulated with 100 nM isoproterenol (ISO) or 10 µM FSK + 100 µM IBMX; the average FRET ratios over time were plotted as a trace. (D) The average 
maximal increases in AKAR3 FRET ratio in NC and HFD myocytes were plotted. ****, P ≤ 0.0001 by one-way ANO VA followed by post hoc Bonferroni test. 
(E) Adult mouse cardiomyocytes expressing the cGMP biosensor, cGI500, for 45–46 h were stimulated with 50 µM SNP. FRET ratio is plotted over time. 
(F) Adult mouse cardiomyocytes expressing the CaMKII biosensor, Camui, for 45–46 h were stimulated with 200 µM Ca2+. FRET ratio is plotted over time. (G) Adult 
mouse cardiomyocytes expressing the cAMP biosensor, EpacSH187, for 35–36 h were stimulated with 10 µM FSK + 100 µM IBMX. FRET ratio is plotted over time. 
(H) The average maximal changes in FRET ratio from E, F, and G are graphed. Error bars represent ±SEM.
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Meanwhile, HEP ES and BSA were added in an attempt to fur-
ther eliminate fluorescence spots of blebbistatin. 10 mM HEP ES 
and 0.2% BSA were effective at reducing precipitation of bleb-
bistatin on the coverslips. HEP ES is a Good’s buffer zwitterion, 
which has been previously implemented in cultures of adult 
mouse cardiomyocytes (Kabaeva et al., 2008; Ackers-Johnson et 
al., 2016). HEP ES can interact with compounds and proteins in 
solution in a way that allows them to stay biochemically avail-
able and soluble (Good et al., 1966; Sledź et al., 2010). HEP ES may 
interact with blebbistatin in a similar fashion to prevent precip-
itation. BSA’s main biological function is to keep a wide variety 
of substances soluble and buffered in blood (Francis, 2010), and 
BSA has been previously supplemented in cardiomyocyte cul-
ture media (Kabaeva et al., 2008; Ackers-Johnson et al., 2016). 
Interestingly, 0.2% BSA supplemented by itself increases the 
fluorescence spotting on the coverslips, but it improves cell at-
tachment and health in culture and reduces the number of cells 
that shrink when placed under UV light. BSA also biologically 
acts as an antioxidant, stabilizes enzymes and biomolecules, 
and buffers ions in the media (Francis, 2010), which may be the 
mechanisms by which the BSA improves cell quality in these 
culturing conditions. Together, it is recommended that both be 
supplemented for culturing adult mouse myocytes for FRET. In 
addition, ITS and taurine, respectively, were tested in the media, 
but no improvement in culture quality was observed. Insulin can 
greatly change cellular metabolism, while taurine physiologically 
modifies calcium ion channel activity in the heart (Schaffer et 
al., 2010). Because many models of heart disease include changes 
in metabolism (Riehle and Abel, 2016) and calcium ion channel 
activity (Bers, 2008) and no improvement in the cell quality was 
observed, it is inadvisable to use insulin and taurine in cell cul-
tures for FRET studies in adult mouse cardiomyocytes.
The implementation of the formulated adult mouse myocyte 
medium has allowed for FRET assays to be enacted with a va-
riety of FRET biosensors including the PKA biosensor AKAR3, 
the cAMP biosensor Epac-SH187, the CaMKII biosensor Camui, 
and the cGMP biosensor cGi500. Although the optimized bleb-
bistatin-containing medium improves cell morphology, reduces 
autofluorescent spots, and curtails cell shrinking under UV light, 
there is a limit to how long cells can remain viable for the FRET 
assay. We found that the optimal time, with any sensor, that 
the adult cardiomyocytes were responsive in FRET assays was 
35–50 h after infection. After 50 h, the cells often shrink under 
UV light. Those cells that do not shrink respond poorly to stim-
uli. There was an increase in cleaved caspase 9 at the 40-h time 
point, which may explain why cells tended to shrink at later time 
points, as active caspase 9 may be associated with cell shrink-
age (Zimmermann et al., 2001). Meanwhile, the expression of 
biosensors also affects the optimal windows to measure the cell 
response: too low of expression yields high noise-to-signal ratio 
whereas high fluorescence intensity interferes with the FRET re-
sponse after stimulation. For example, PKA biosensors still gave 
Table 2. FRET sensor expression in adult mouse cardiomyocytes
FRET 
probe
Citation Full name Detects Donor Acceptor Linker FRET 
time 
window 
(h)
Basal 
YFP 
intensity 
(a.u.)
Basal 
CFP 
intensity 
(a.u.)
Maximum 
YFP 
intensity 
(a.u.)
Maximum 
CFP 
intensity 
(a.u.)
AKAR3 Allen and 
Zhang, 
2006
A kinase 
activity 
reporter 3
PKA 
activity
eCFP Tandem 
cp173Venus 
pair
Binding domain 
from kemptide 
and substrate 
domain from 
14-3-3, with a 
14-aa sequence 
in between
35–50 980–
1,010
313–330 1,049–
1,080
255–265
cGi500 Russwurm 
et al., 2007
cGMP 
indicator-500 
nM
[cGMP] eCFP eYFP Cyclic nucleotide 
monophosphate 
binding 
domains A and 
B from PKG 
(Gln79-Tyr345)
35–50 3,803–
3,901
1,049–
1,101
3,471–
3,207
1,143–
1,208
Camui Takao et 
al., 2005
Camui CaMKII 
activity
CFP-S175G Venus Rat CaMKIIα 35–50 5,366–
5,410
1,561–
1,610
5,140–
5,190
1,655–
1,701
ICUE3 DiPilato 
and Zhang, 
2009
Indicator of 
cAMP using 
Epac
[cAMP] eCFP Tandem 
cp194Venus 
pair
Epac1 n/a 2,108–
2,210
660–810 2,120–
2,209
659–808
Epac-SH187 Klarenbeek 
et al., 2015
Epac-based 
sensor 
#H187
[cAMP] mTurquoise2 Tandem 
cp173Venus 
pair
Catalytically 
dead Epac1 
with deletion of 
the membrane 
targeting 
sequence and a 
point mutation 
of Q270E
30–40 1,624–
1,709
246–260 1,186–
1,198
353–369
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responses at the 50-h time point, whereas CaMKII biosensors 
became unresponsive much sooner. Hence, both cell health and 
biosensor design affect the time window at which FRET assays 
can be performed.
Despite that this diverse array of CFP/YFP sensors are effec-
tive in this method, not all sensors attempted were equally effica-
cious. Although the fourth-generation cAMP sensor, Epac-SH187, 
worked well, the third-generation cAMP sensor, ICUE3, did not, 
which is probably because of the different designs of the sensors. 
ICUE3 is based on the full length of exchange protein directly acti-
vated by cAMP (Epac); the membrane targeting sequence on Epac 
may make the endoplasmic reticulum expression and processing 
of the ICUE3 biosensor difficult, resulting in a low expression 
level in adult myocytes. In contrast, Epac-SH187 incorporates very 
bright and highly photobleach-resistant donor and acceptor, as 
well as a smaller linker composed of Epac with the membrane 
targeting sequence removed and a point mutation that increases 
the calcium affinity by 2.5-fold (Klarenbeek et al., 2015). There-
fore, Epac-SH187 allows stronger and brighter sensor expression 
to detect cAMP dynamics in adult cardiomyocytes 30–40 h after 
infection. The data from cells expressing the cGi500 biosensor 
for cGMP display a clear response to cotreatment with forskolin 
and IBMX, but the change in FRET ratio was small. cGi500 has 
an EC50 for cGMP of 500 µM (Russwurm et al., 2007), which is 
probably not optimized to detection of cGMP concentrations in-
duced by neurohormonal stimuli. Another cGMP biosensor, red-
cGES-DE5, has an EC50 of ∼40 nM (Nikolaev et al., 2006; Bork 
and Nikolaev, 2018) and could be used to detect small changes in 
cGMP concentration that are often present in cardiomyocytes.
In the future, implementation of this method with other bi-
osensors, including biosensors localized to certain locations in 
the cell and combined with the new scanning ion conductance 
microscopy/FRET technology (Wright et al., 2014; Bazzazi et al., 
2015; Barbagallo et al., 2016; Surdo et al., 2017) will be useful 
in determining the spatiotemporal dynamics of signaling cas-
cades in cardiomyocytes. When applying FRET analysis with 
localized biosensors, it is important to consider how different 
compartments of the cell might be affected by blebbistatin. For 
example, one should remain cautious when measuring signal 
transduction with FRET biosensors targeted onto the myofil-
aments (Barbagallo et al., 2016), because blebbistatin inhibits 
myosin II and can decrease rigid actin-myosin cross-bridge 
formation (Kovács et al., 2004). Modeling studies suggest that 
decreases in cross-bridge formation can lead to decreases in 
troponin calcium sensitivity (Sich et al., 2010), but studies in 
permeabilized mouse cardiac fibers and skinned rat trabecu-
lae suggest that blebbistatin-inhibited cells have no change in 
calcium dynamics compared with uninhibited cells, although 
contractility is inhibited (Dou et al., 2007; Farman et al., 2008). 
Future study using targeted FRET biosensors in larger species’ 
cardiomyocytes may also be able to shed light on alterations 
that blebbistatin may impart on the myofilament of mouse 
cardiomyocytes.
Another limitation to this newly developed culture method is 
that the cultured cells may undergo alterations in fine structural 
and biochemical properties that cannot be detected by fluores-
cence microscope imaging and Western blotting. These alter-
ations may cause the cells to no longer contract in response to 
pacing after extended culture time and exposure to blebbistatin. 
Although the Nikolaev group has recently published an article 
showing that there is no difference in adrenergic-induced cAMP 
production in paced and quiescent cells, further explorations 
using FRET methodology of paced cells should be done in freshly 
isolated cells that come from transgenically expressing FRET sen-
sor mice (Sprenger et al., 2015).
In summary, we have defined a general media formula to 
accommodate expression of a set of FRET biosensors during 
extended culture in adult mouse cardiomyocytes, allowing anal-
ysis of dynamic signaling transduction in living adult myocytes. 
Blebbistatin supplemented at a low concentration of 6.25 µM is 
effective at maintaining adult mouse cardiomyocyte morphology 
in culture for up to 50 h for FRET assays. The addition of HEP ES 
and BSA to the media further reduces autofluorescent spotting of 
blebbistatin and improves cell quality, which improves overall sig-
nal-to-noise ratio during FRET experiments. This robust culturing 
process will allow for detailed single-cell time-sensitive measure-
ments of signaling events. This opens the door to allow the myriad 
of genetic and pathological mouse models to be adopted for FRET 
experimentation. In the future, in addition to the biosensors tested 
here, subcellularly targeted FRET biosensors can be assessed for 
fine-tuned spatiotemporal dynamics inside mouse cardiomyo-
cytes, allowing scientists to disentangle complicated signaling 
networks important in health and disease of cardiomyocytes.
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